Javascript must be enabled to continue!
Cryptogenic Stroke in the Young
View through CrossRef
Abstract
Context:
Strokes that remain without a definite cause even after an extensive workup, termed cryptogenic strokes, constitute up to 30–40% of ischemic strokes (ISs) in the young. Some of them can have a genetic basis. However, the well-established genetic causes account for only a small percentage of these cases.
Aim:
To evaluate the association of cryptogenic young IS with 16 candidate gene polymorphisms.
Settings and Design:
A case-control study with cryptogenic young IS patients (South and North Indians;
n
= 105) and age, sex, and ethnicity-matched controls (
n
= 215).
Subjects and Methods:
Genotyping was carried out by PCR-RFLP method using DNA extracted from the blood.
Statistical Analysis Used:
Association of the genotypes with the disease was studied using Chi-square test.
Results:
MTHFR rs1801133 and KNG1 rs710446 showed significant statistical association with cryptogenic young IS (
P
= 0.0261 and 0.0157, respectively) in the Indian population. Significant association of KNG1 rs710446 (
P
0.0036) and FXII rs1801020 (
P
0.0376) with cryptogenic young stroke in South Indian males, SERPINC1 rs2227589 in South Indian female patients (
P
= 0.0374), and CYP4V2 rs13146272 in North Indian males (
P
= 0.0293) was observed.
Conclusions:
Our study indicates that in the Indian population MTHFR rs1801133, KNG rs710446, FXII rs1801020, SERPINC1 rs2227589, CYP4V2 rs13146272, and FXIII V34L may be significant risk factors for cryptogenic IS in the young. In addition, ethnicity and gender play a significant role. Further studies with larger sample size are required to completely establish these polymorphisms as risk factors for cryptogenic IS in young Indians.
Ovid Technologies (Wolters Kluwer Health)
Title: Cryptogenic Stroke in the Young
Description:
Abstract
Context:
Strokes that remain without a definite cause even after an extensive workup, termed cryptogenic strokes, constitute up to 30–40% of ischemic strokes (ISs) in the young.
Some of them can have a genetic basis.
However, the well-established genetic causes account for only a small percentage of these cases.
Aim:
To evaluate the association of cryptogenic young IS with 16 candidate gene polymorphisms.
Settings and Design:
A case-control study with cryptogenic young IS patients (South and North Indians;
n
= 105) and age, sex, and ethnicity-matched controls (
n
= 215).
Subjects and Methods:
Genotyping was carried out by PCR-RFLP method using DNA extracted from the blood.
Statistical Analysis Used:
Association of the genotypes with the disease was studied using Chi-square test.
Results:
MTHFR rs1801133 and KNG1 rs710446 showed significant statistical association with cryptogenic young IS (
P
= 0.
0261 and 0.
0157, respectively) in the Indian population.
Significant association of KNG1 rs710446 (
P
0.
0036) and FXII rs1801020 (
P
0.
0376) with cryptogenic young stroke in South Indian males, SERPINC1 rs2227589 in South Indian female patients (
P
= 0.
0374), and CYP4V2 rs13146272 in North Indian males (
P
= 0.
0293) was observed.
Conclusions:
Our study indicates that in the Indian population MTHFR rs1801133, KNG rs710446, FXII rs1801020, SERPINC1 rs2227589, CYP4V2 rs13146272, and FXIII V34L may be significant risk factors for cryptogenic IS in the young.
In addition, ethnicity and gender play a significant role.
Further studies with larger sample size are required to completely establish these polymorphisms as risk factors for cryptogenic IS in young Indians.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...
Oral anticoagulants or antiplatelets for cryptogenic stroke: a systematic review and meta-analysis
Oral anticoagulants or antiplatelets for cryptogenic stroke: a systematic review and meta-analysis
Abstract
Background
Cryptogenic strokes comprise 20 to 30% of ischemic strokes and include a substantial proportion classified a...
P60 THE ELECTROPHYSIOLOGICAL DIAGNOSIS OF THE CRYPTOGENETIC STROKE
P60 THE ELECTROPHYSIOLOGICAL DIAGNOSIS OF THE CRYPTOGENETIC STROKE
Abstract
Introduction
In the neurological field, one of the pathologies not yet fully clarified from an etiopathogenetic point o...
Heterogeneity among women with stroke: health, demographic and healthcare utilization differentials
Heterogeneity among women with stroke: health, demographic and healthcare utilization differentials
Abstract
Background
Although age specific stroke rates are higher in men, women have a higher lifetime risk and are more likely to die from a stroke...
Premature atrial contractions and their associations with cryptogenic strokes
Premature atrial contractions and their associations with cryptogenic strokes
Objective: To assess the association between premature atrial contractions and cryptogenic stroke while comparing the prevalence of premature atrial contractions among cryptogenic ...
Atrial Septal Abnormalities and Cryptogenic Stroke: A Cross-Sectional
Study
Atrial Septal Abnormalities and Cryptogenic Stroke: A Cross-Sectional
Study
Background:
Cryptogenic stroke, whose underlying pathology is unknown, accounts
for 30-40% of all ischemic strokes. Studies have mentioned the association between atrial septal
abn...
Scoping Review of Existing Stroke Guidelines; Argument for a Value-Added Change
Scoping Review of Existing Stroke Guidelines; Argument for a Value-Added Change
Abstract
Background and Purpose
Stroke represents one of the most important causes of morbidity ( eighty million patients with ...

